Safety and Efficacy of Intrapulmonary Percussive Ventilation in Preterm Infants

Safety and Efficacy of Intrapulmonary Percussive Ventilation in Preterm Infants

The purpose of this study is to evaluate the benefits and safety of Intrapulmonary Percussive Ventilation in preterm infants. IPV has been demonstrated to be safe, and improve airway secretions clearance and decreased atelectasis in pediatric patients. We aim to evaluate the effects of IPV in preterm infants.

INCLUSION CRITERIA

• Premature infants born before 32 weeks of gestation with birth weight less than 1500 grams.
• Infants requiring positive pressure ventilation by 14 days of life. EXCLUSION CRITERIA
• Infants with known or suspected chromosomal anomalies (Trisomy 13, 18, 21)
• Infants with Congenital Diaphragmatic Hernia
• Presence of air leak syndrome (pneumothorax, pneumomediastinum)
• Previous diagnosis of air leak syndrome.